www.rupeedesk.in
Pharmaceutical stocks are seen mixed next week with a positive bias. Since many crucial data are awaited in the next couple of weeks, investors would not go in for high-risk, high-beta stocks but for defensive stocks such as pharmaceuticals and fast-moving consumer goods. Next week, investor focus will be on India's industrial production data for January, due Tuesday, and Wholesale Price Index-based inflation rate for February, due Thursday. We would also closely watch the Reserve Bank of India's mid-quarter monetary policy review on Mar 19. Ranbaxy Laboratories is seen Consolidating next week. Talking about Sun Pharmaceuticals Industries, the stock has been trading in its life-time-high position and there were chances of partial profit booking in the stock.
